NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CroíValve

CroíValve

Private
DublinHealthcare & Life Scienceshttps://www.croivalve.com/

Last Round

Series B

Jun 23, 2026

Total Funding Raised

$64.71M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CroíValve is a medical device company developing a minimally invasive transcatheter valve system for the treatment of tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

tricuspid regurgitationtranscatheter heart valveminimally invasive surgerystructural heartinterventional cardiologyheart valve repairmedical devicepercutaneous valve repairclinical trialTAVRtranscatheter valvecardiovascular devicemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CroíValve Comparables

Compare CroíValve with similar companies based on industry and business-model similarity.

CroíValve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Coramaze Technologies
90%
Trisol Medical
89%
VDyne
89%

CroíValve Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 23, 2026
AcceleratorJul 2, 2025
Series BAug 7, 2024
Series AFeb 4, 2022
VC RoundSep 12, 2019
Seed
Mar 28, 2019

Key People

Founding team and executive leadership

Shauna Clarke

Chief Financial Officer

Executive Team

CroíValve Investors

Notable investors and investment history

CroíValve investors
InvestorRounds
Atlantic Bridge CapitalSeries B, Series A, Seed
European Innovation Council FundAccelerator
Furthr VCSeries B
IAG Capital PartnersSeries B
AscentifiSeries B, Series A
BGFSeries B
Dublin Business Innovation CentreSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $20M round with BGF and EIC Fund participating.

  • Jan 16, 2026

    Collaboration to simulate clinical implantation procedures for cardiac technology.

CroíValve Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CroíValve Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CroíValve's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range53
Year Founded2016
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.